India Pharma Medical Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apr 5, 2021
Speaking on the occasion Shri DV Sadananda Gowda commended India’s capabilities as a global and reliable supplier of drugs and medical devices during the COVID-19 pandemic. Citing the recent UNCTAD report, he also pointed out India’s positive FDI growth even with a decline in FDI of 42% globally.  Shri Gowda said, “As the pandemic exposed the global vulnerabilities of the supply chains in the pharmaceuticals sector, the Department of Pharmaceuticals launched the Production Linked Incentive Scheme for bulk drugs, with a financial outlay of ₹6,940 crores across 53 APIs over 6 years. For Medical Devices, another PLI scheme was announced with an outlay of ₹3,420. Such interventions & incentives have played an instrumental role in realizing Prime Minister’s vision of ‘Aatmanirbhar Bharat’, or India for the world.” ....

New Delhi , Shri Piyush Goyal , Shri Mandaviya , Atmanirbhar Bharat , Shri Mansukhl Mandaviya , Aatmanirbhar Bharat , Shri Gowdafurther , Shri Gowda , Shri Dv Sadananda Gowda , Department Of Pharma , Glenmark Pharmaceuticals , Ministry Of Chemicals , Ministry Of Chemicals Fertilizers , Department Of Pharmaceuticals , Ministry Of Commerce , Pharma Bureau , Laurus Labs , Programme Of The Year Award , Union Chemicals , Wrignanosystems Private , Consumer Affairs , Global Investors , India Pharma , Medical Devices , Public Distribution Shri Piyush Goyal , Indian Pharmaceutical Industry ,